Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1636 1653 1656
This examiner grants 58% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18641299 | ADENOSINE NUCLEOBASE EDITORS AND USES THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 19071055 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | Non-Final OA | Halozyme, Inc. |
| 18548640 | REDUCING HIGH MANNOSE GLYCAN PROTEIN EXPRESSION USING GUANOSINE 5'-MONOPHOSPHATE | Non-Final OA | MERCK SHARP & DOHME LLC |
| 18278695 | METHODS FOR GENERATING A CRISPR ARRAY | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18016428 | COMPOSITIONS AND METHODS FOR TREATING AN INHERITED RETINAL DISEASE | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17997877 | ACE2 COMPOSITIONS AND METHODS | Final Rejection | The Regents of the University of California |
| 17767844 | METHODS TO STABILIZE MAMMALIAN CELLS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17826545 | CELL CULTURE METHOD, ANTIBODY PRODUCTION METHOD, ORGANIC ACID REMOVAL METHOD, AND ANTIBODY | Non-Final OA | FUJIFILM Corporation |
| 17921035 | CHIMERIC POLYPEPTIDES AND METHODS OF PREPARING SAME | Non-Final OA | RAMOT AT TEL-AVIV UNIVERSITY LTD. |
| 17726324 | GENETICALLY MODIFIED RECOMBINANT CELL LINES | Final Rejection | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
| 17604714 | METHODS OF IMPROVING THE LONGEVITY OF IMMUNE CELLS | Non-Final OA | University of Houston System |
| 17620557 | PRODUCTION OF VECTORS USING PHAGE ORIGIN OF REPLICATION | Final Rejection | ASKBIO INC. |
| 18014348 | CLEANING COMPOSITIONS AND USES THEREOF | Non-Final OA | Henkel AG & Co. KGaA |
| 17786561 | CLEANING COMPOSITIONS COMPRISING DISPERSINS VIII | Final Rejection | Henkel AG & Co. KGaA |
| 17820488 | RETINAL ORGANOID MODEL SYSTEMS | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17930591 | COMPOSITIONS IMMUNOGENIC AGAINST SARS CORONAVIRUS 2, METHODS OF MAKING, AND USING THEREOF | Final Rejection | VERSITECH LIMITED |
| 16978461 | EXPRESSION OF HETEROLOGOUS ENZYMES IN YEAST FOR FLAVOURED ALCOHOLIC BEVERAGE PRODUCTION | Non-Final OA | Danstar Ferment AG |
| 17525433 | CELL ENGINEERING USING RNAs | Non-Final OA | Boehringer Ingelheim International GmbH |
| 17627088 | PRODUCTION OF FUCOSYLLACTOSE IN HOST CELLS | Non-Final OA | INBIOSE N.V. |
| 18680688 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND EXOSPORIUM FRAGMENTS FOR PLANT HEALTH | Non-Final OA | Spogen Biotech Inc. |
| 17635349 | COMPOSITIONS AND METHODS FOR INCREASED PROTEIN PRODUCTION IN BACILLUS LICHENIFORMIS | Non-Final OA | DANISCO US INC. |
| 18002349 | METHOD FOR PRODUCING DIPEPTIDE | Final Rejection | KYOWA HAKKO BIO CO., LTD. |
| 18628548 | METHODS FOR PRODUCING BIOGAS AND RENEWABLE NATURAL GAS USING CO-PRODUCTS FROM A STILLAGE STREAM AS FEEDSTOCKS | Non-Final OA | Marquis IP LLC |
| 18512687 | METHODS, CELLS & ORGANISMS | Final Rejection | Kymab Limited |
| 18444368 | COMPOSITIONS AND METHODS FOR GENE EDITING | Final Rejection | CRISPR THERAPEUTICS AG |
| 18529012 | Microbial Oil/Lipid and Method for Producing Microbial Oil/Lipid | Final Rejection | Nissui Corporation |
| 18376543 | Composition and Method of an Orally Administered Antimicrobial Peptide Vectored in a Bacterial Expression Vehicle | Non-Final OA | The United States of America as represented by the Secretary of Agriculture |
| 17908007 | Undenatured Type II Collagen in Animal Food and Treats | Final Rejection | Lonza Greenwood LLC |
| 18252283 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID ISOLATION | Non-Final OA | LIFE TECHNOLOGIES AS |
| 18248865 | NOVEL PIGGYBAC TRANSPOSON SYSTEM AND USE THEREOF | Non-Final OA | SHANGHAI JUNCELL THERAPEUTICS CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy